Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
-
desktop_windows
Effect of art therapy on breast cancer patients' quality of life: Literature review
Riya Thomas | ABS Conference 2024
13.05.2024 | Added: 29.07.2024
Classifications: Post Treatment Surveillance & Care
desktop_windowsWebcast desktop_windows -
menu_book
This study evaluates the long term risk of invasive breast cancer and breast cancer related death following non-screen detected DCIS diagnosis. This risk was compared to the general population and to ...
Gurdeep S Mannu et al | British medical Journal
16.11.2023 | Added: 16.11.2023
Classifications: Breast Cancer Treatment
Keywords: DCIS Symptomatic Invasive Breast Cancer
menu_bookPublication menu_book -
menu_book
Mastitis and Mammary Abscess Management Audit (MAMMA) in the UK and Ireland
MAMMA describes the current practice in management of mastitis and breast abscess in UK and Ireland, with a specific focus on the rate of surgical intervention. From 69 participating hospitals, 1312 p...
Alona Courtney et al | British Journal of Surgery
31.10.2023 | Added: 31.10.2023
Classifications: Benign & Atypical Breast Disease
menu_bookPublication menu_book -
desktop_windows
This systemic review identified primary research studies (2000-2022) which evaluated clinical or patient-reported outcomes for women who underwent contralateral mastectomy without reconstruction after...
Cora Griffin et al | Annals of Surgical Oncology
25.09.2023 | Added: 25.09.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Contralateral mastectomy
desktop_windowsWebcast desktop_windows -
menu_book
Oreste Davide Gentilini et al | JAMA Oncology
21.09.2023 | Added: 21.09.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Sentinel Lymph Node Biopsy/ SLNB Trials Axilla
menu_bookPublication menu_book -
desktop_windows
What constitutes a good consultation when informing patients about breast reconstruction?
Ms Samantha Sloan | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
desktop_windowsWebcast desktop_windows -
desktop_windows
Re-excision rates based on data from the National Audit of Breast Cancer in Older Patients
Professor Kieran Horgan | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
desktop_windowsWebcast desktop_windows -
desktop_windows
Radiotherapy toxicity in patients undergoing oncoplastic breast surgery - the surgeons' perspective
Mr Tim Rattay | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Breast Reconstruction Radiotherapy
desktop_windowsWebcast desktop_windows -
desktop_windows
Do all patients with invasive breast cancer need an axillary USS?
Professor Michael Douek | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Axilla Ultrasound
desktop_windowsWebcast desktop_windows -
desktop_windows
Comparison study of obese and non-obese patients undergoing implant reconstruction with ADM
Mr John Mathew | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Acellular Dermal Matrix/ ADM
desktop_windowsWebcast desktop_windows -
desktop_windows
Are patients being appropriately consented for implant- based breast reconstruction (IBR)?
Miss Lisa Sheehan | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Implant based breast reconstruction
desktop_windowsWebcast desktop_windows -
desktop_windows
ALDH1 and CD44 serve as prognostic markers in patients with breast cancer
Professor Diptendra Kumar Sarkar | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast Cancer Treatment
Keywords: Prognostic Markers
desktop_windowsWebcast desktop_windows -
menu_book
Age and sex can predict cancer risk in people referred with breast symptoms
Over the last decade, more than 5 million patients were referred to secondary care with breast symptoms. In 2021-22, 40% of referred patients waited longer than the recommended 14 days for clinic asse...
Toral Gathani et al | British medical Journal
26.04.2023 | Added: 26.04.2023
Classifications: Breast Cancer Risk
Keywords: High risk factors
menu_bookPublication menu_book -
menu_book
MonarchE is an open-label, randomised, phase 3 trial which recruited high risk hormone receptor positive, HER2 receptor negative, node-positive breast cancer patients (n=5637). Patients were randomise...
Prof Stephen R D Johnston, MD et al | The Lancet Oncology
06.12.2022 | Added: 06.12.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment Endocrine therapy Trials
menu_bookPublication menu_book -
menu_book
The AMAROS trial evaluated axillary lymph node dissection (ALND; n=744) vs. axillary radiotherapy (ART; n=681) in patients with cT1-2 breast cancer with positive sentinel lymph node biopsy (SLNB). The...
Sanne A.L Bartels,MD,Phd,MSc et al | Journal of Clinical Oncology
16.11.2022 | Added: 16.11.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Axilla Sentinel Lymph Node Biopsy/ SLNB Trials Radiotherapy
menu_bookPublication menu_book -
menu_book
This study examines the impact of the COVID-19 pandemic on breast cancer diagnostic services using publicly available data sources (Cancer Waiting Time data / NHSBSP annual report / COVID-19 Rapid Can...
Toral Gathani et al | British Journal of Cancer
12.11.2022 | Added: 12.11.2022
Classifications: Screening & Diagnosis
Keywords: Symptomatic COVID-19
menu_bookPublication menu_book -
menu_book
Targeted axillary dissection (TAD) involves targeted lymph node biopsy and SLNB. SenTa study is a prospective registry study conducted across 50 centres which aims to investigate the feasibility and a...
Sherko Kuemmel et al | National Library of Medicine
01.11.2022 | Added: 01.11.2022
Classifications: Breast & Oncoplastic Surgery
menu_bookPublication menu_book -
menu_book
This prospective multicentre cohort study aimed to determine surgical decision-making in the breast and axilla, as well as pathological complete response (pCR) rate in patients undergoing neoadjuvant ...
Hiba Fatayer et al | British Journal of Surgery
09.09.2022 | Added: 09.09.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Early Breast Cancer Trials
menu_bookPublication menu_book
